Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 2
2004 4
2005 7
2006 9
2007 10
2008 7
2009 7
2010 3
2011 10
2012 6
2013 12
2014 7
2015 11
2016 4
2017 3
2018 10
2019 5
2020 5
2021 10
2022 7
2023 9
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Results by year

Filters applied: . Clear all
Page 1
Multimodal kreftbehandling av gastrointestinal stromal tumor.
Hompland I, Hølmebakk T, Boye K, Stoldt S, Bjerkehagen B, Berner JM, Wiedswang AM, Revheim ME, Poulsen JP, Hall KS, Bruland ØS. Hompland I, et al. Tidsskr Nor Laegeforen. 2018 Oct 1;138(15). doi: 10.4045/tidsskr.18.0200. Print 2018 Oct 2. Tidsskr Nor Laegeforen. 2018. PMID: 30277049 Free article. Review. Norwegian.
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial.
Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, Baldini EH, Jebsen NL, Scholten AN, van den Ende PLA, Krol ADG, Ubbels JF, van der Hage JA, van Werkhoven E, Klomp HM, van der Graaf WTA, van Coevorden F, Schrage Y, van Houdt WJ, Haas RL. Lansu J, et al. Among authors: bruland os. JAMA Oncol. 2021 Jan 1;7(1):e205865. doi: 10.1001/jamaoncol.2020.5865. Epub 2021 Jan 21. JAMA Oncol. 2021. PMID: 33180100 Free PMC article. Clinical Trial.
Editorial: Targeted alpha particle therapy in oncology.
Bruland ØS, Larsen RH, Baum RP, Juzeniene A. Bruland ØS, et al. Front Med (Lausanne). 2023 Mar 7;10:1165747. doi: 10.3389/fmed.2023.1165747. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36960341 Free PMC article. No abstract available.
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma.
Mensali N, Köksal H, Joaquina S, Wernhoff P, Casey NP, Romecin P, Panisello C, Rodriguez R, Vimeux L, Juzeniene A, Myhre MR, Fåne A, Ramírez CC, Maggadottir SM, Duru AD, Georgoudaki AM, Grad I, Maturana AD, Gaudernack G, Kvalheim G, Carcaboso AM, de Alava E, Donnadieu E, Bruland ØS, Menendez P, Inderberg EM, Wälchli S. Mensali N, et al. Among authors: bruland os. Nat Commun. 2023 Jun 8;14(1):3375. doi: 10.1038/s41467-023-39097-x. Nat Commun. 2023. PMID: 37291203 Free PMC article.
[Cancer therapy with isolated limb perfusion].
Spasojevic M, Mariathasan AB, Frich L, Bruland ØS, Larsen SG, Stoldt S. Spasojevic M, et al. Among authors: bruland os. Tidsskr Nor Laegeforen. 2021 Aug 19;141(2021-12). doi: 10.4045/tidsskr.21.0194. Print 2021 Sep 7. Tidsskr Nor Laegeforen. 2021. PMID: 34505491 Free article. Norwegian.
Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.).
Palmerini E, Reichardt P, Hall KS, Bertulli R, Bielack SS, Comandone A, Egerer G, Hansmeier A, Kevric M, Carretta E, Hansson L, Jebsen N, Eriksson M, Bruland ØS, Donati DM, Ibrahim T, Smeland S, Ferrari S. Palmerini E, et al. Among authors: bruland os. Cancer. 2023 Nov 15;129(22):3564-3573. doi: 10.1002/cncr.34964. Epub 2023 Aug 2. Cancer. 2023. PMID: 37530385
Targeted radio-nuclide therapy of skeletal metastases.
Sartor O, Hoskin P, Bruland OS. Sartor O, et al. Among authors: bruland os. Cancer Treat Rev. 2013 Feb;39(1):18-26. doi: 10.1016/j.ctrv.2012.03.006. Epub 2012 Apr 24. Cancer Treat Rev. 2013. PMID: 22534284 Review.
139 results